Lanreotide Impurity 14 CAS CATO-C4X-237014
| CAS No. | CATO-C4X-237014 |
| Molecular Formula | C108H138N22O20S4 |
| Molecular Weight | 2192.65 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a process- or degradation-related impurity, Lanreotide Impurity 14 (CAS CATO-C4X-237014, C108H138N22O20S4) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Lanreotide Impurity 14 (C108H138N22O20S4) contains a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage. It is notably hygroscopic, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a certified reference material (CRM), Lanreotide Impurity 14 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C108H138N22O20S4 |
| Molecular Weight | 2192.65 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 51.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 22 |
| Sulfur Atoms | 4 |
Related Lanreotide Standards
- Lanreotide Impurity 11 (CAS CATO-C4X-237011)
- Lanreotide Impurity 32 (CAS 182482-12-8)
- Lanreotide Impurity 12 (CAS CATO-C4X-237012)
- Lanreotide Impurity 13 (CAS 209006-25-7)
- Lanreotide Impurity 15 (CAS CATO-C4X-237015)
- Lanreotide (CAS 108736-35-2)
- Lanreotide Acetate (CAS 127984-74-1)
- Lanreotide Acetate (CAS 108736-35-2（free base）)
Recommended Standards
- T-Peptide (CAS 2022956-62-1)
- (Cys2)-Neuropeptide Y-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32) (H-3298.0500) (CAS 128806-04-2)
- Galanin (1-13)-Substance P (5-11) amide (CAS 138579-66-5)
- Hepcidin-20 (human) trifluoroacetate salt (CAS 342790-23-2)
- Dronedarone Impurity 11 (CAS CATO-C4X-109211)
- Mefatinib Impurity 18 (CAS CATO-C4X-299218)
- Imrecoxib Impurity 54 (CAS CATO-C4X-237954)
- 4-tert-butoxycarbonyl-1,4-oxazepane-6-carboxylic acid (CAS 1269755-58-9)
- 3,6-Bis(dimethylamino)-9H-thioxanthen-9-one (CAS 7031-01-8)
- Ethyl 2-iodo-2-(triphenylphosphoranylidene)acetate (CAS 26480-87-5)
- 2-(1,2-benzothiazol-3-yl)acetonitrile (CAS 37839-44-4)
- 2-Methyl-5-(trifluoromethyl)quinazolin-4(3H)-one (CAS 1956370-25-4)
- 2-(4-Nitrophenyl)oxazolo[5,4-d]pyrimidin-7-ol (CAS 937600-39-0)
- Semaglutide impurity 89 (CAS CATO-C4X-222689)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com